corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 114 of 144 pages ‹ First  < 112 113 114 115 116 >  Last ›

HSL363
Abboud L.
Lilly's New Pill For Depression Reopens Debate
The Wall Street Journal 2004 May 28

HSL2279
Garcia-Berthou E, Alcaraz C.
Incongruence between test statistics and P values in medical papers.
BMC Med Res Methodol 2004 May 28; 4:13:
http://www.biomedcentral.com/1471-2288/4/13

HSL360
Randerson J.
Antibiotics linked to huge rise in allergies
NewScientist.com 2004 May 27

HSL361
Italy police probe 4,400 doctors
BBC News 2004 May 27

HSL362
Windham C.
AMA to Propose Broad Database For Clinical Trials
Wall Street Journal 2004 May 27

HSL488
Garnaut J.
Plum jobs for US trade deal advisers
The Sydney Morning Herald 2004 May 27

HSL359
Buchanan K.
MP brands pill-making firms 'disease mongers'
The Western Mail 2004 May 26

HSL19809
Chan A-W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG
Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials: Comparison of Protocols to Published Articles
JAMA 2004 May 26; 291:(20):2457-2465
http://jama.ama-assn.org/content/291/20/2457.abstract

HSL358
First, Do No Harm
The Wall Street Journal 2004 May 25

HSL487
Pear R.
In a Shift, Bush Moves to Block Medical Suits
The New York Times 2004 May 25

HSL486
Basu I.
India's clinical trials and tribulations
Asia Times Online 2004 May 23
http://www.atimes.com/atimes/South_Asia/FG23Df03.html

HSL124
Lenzer J.
Pfizer pleads guilty, but drug sales continue to soar.
BMJ 2004 May 22; 328:(7450):1217
http://bmj.bmjjournals.com/cgi/content/full/328/7450/1217

HSL125
Gibson L.
Move to sell statins over the counter raises concerns.
BMJ 2004 may 22; 328:(7450):1221
http://bmj.bmjjournals.com/cgi/content/full/328/7450/1221-b

HSL352
Darragh D.
Mum free after murder bid
The West Australian 2004 May 22

HSL349
Mokhiber R.
Tuna Meltdown
2004 May 21

HSL350
Ranald P.
Trade text shows up freedom to lose
Newcastle Herald 2004 May 21

HSL342
Allen L.
Claims of soaring drug prices under FTA
Financial Review 2004 May 20

HSL343
Bradley M.
Drug prices will rocket, experts warn
Sydney Morning Herald 2004 May 20

HSL344
Colebatch T, Wilkinson M.
Labor warns it may block trade deal
The Age 2004 May 20

HSL345
Davidson K.
Why is Howard so loyal to US businesses?
The Age 2004 May 20

HSL346
Mitchell P.
US trade deal raises prescriptions
The Australian 2004 May 20

HSL347
Priest A.
Pondering Male Menopause
Straight.com 2004 May 20

HSL348
Bivens M.
Irrational Rationing
The Nation 2004 May 20

HSL338
McGrath C.
Study predicts trade agreement will cost PBS $1.5-bil
ABC News 2004 May 19

HSL339
Becker E.
Trade Deal Opens Australia to U.S. Manufactured Goods
2004 May 19

HSL341
Lester T.
Trade agreement may threaten PBS
ABC News 2004 May 19

HSL337
New York Sues GlaxoSmithKline Over Paxil
Associated Press 2004 May 18

HSL335
Johnson L.
Behavior drugs top kids' prescriptions: More spent than on antibiotics, asthma therapy
The New York Post 2004 May 17

HSL336
Moore P.
Gifts for Ehrlich baby raise ethical questions
The Baltimore Sun 2004 May 17

HSL334
Japsen B.
Medicine's gift culture put in an uncomfortable light
The Chicago Tribune 2004 May 16

HSL126
Burton B.
Generics industry and doctors nervous over free trade deal.
BMJ 2004 May 15; 328:(7449):1158
http://bmj.bmjjournals.com/cgi/content/full/328/7449/1158-a

HSL333
Lenzer L.
Whistleblower removed from job for talking to the press
The British Medical Journal 2004 May 15

HSL16202
Angell M.
The Truth About the Drug Companies
The New York Review of Books 2004 May 15

HSL18037
Tayal U
No Free Lunch
BMJ 2004 May 15; 328:(7449):199
http://careerfocu.bmjjournals.com/cgi/content/full/328/7449/199

HSL331
Armstrong D.
Pfizer Case Signals Tougher Action On Off-Label Drug Use
The Wall Street Journal 2004 May 14

HSL332
Harris G.
Pfizer to Pay $420 Million in Illegal Marketing Case
The New York Times 2004 May 14

HSL19929
Parnell K
What degree of separation in advertising and editorial?
Australian Doctor 2004 May 1426

HSL330
Mishra R.
Lapses cited in Harvard clinical trials
The Boston Globe 2004 May 13

HSL490
Weinberg P.
Fired scientists spoke out on drug approvals
Rabble News 2004 May 13

HSL5383
US Department of Justice
Warner-Lambert to pay $430 million to resolve criminal & civil health care liability relating to off-label promotion
US Department of Justice 2004 May 13
http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm

HSL7454
Kaiser Network.
Pfizer Settles Neurontin Medicaid Fraud Case for $430 Million
Kaiser Daily Reports 2004 May 13
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=23702

HSL329
Pollack A.
Suit Charges Promotion of Drug's Off-Label Use
The New York Times 2004 May 12

HSL437
Freudenheim .
Big Employers Join Forces in Effort to Negotiate Lower Drug Prices
The New York Times 2004 May 12

HSL485
Becker E.
Trade Agreement May Undercut Importing of Inexpensive Drugs
The New York Times 2004 May 12

HSL328
Silverman E.
Antidepressant prescriptions show decline: Drop follows FDA meeting on links to suicides in kids
Newark Star Ledger 2004 May 11

HSL11698
Sivagnanam G, Thirumalaikolundusubramanian P, Mohanasundaram J, Raaj AA, Namasivayam K, Rajaram S.
A survey on current attitude of practicing physicians upon usage of antimicrobial agents in southern part of India.
MedGenMed 2004 May 11; 6:(2):1
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15266228

HSL327
Health Canada cloaked in secrecy
The Globe and Mail 2004 May 10

HSL483
Letters to the Editor
The Wall Street Journal 2004 May 9

HSL484
Mathews A.
Invasive Procedure After Medtronic Lobbying Push, The FDA Had Change of Heart: Agency Squelches an Article Raising Doubts on Safety Of Device to Repair Artery Threat of 'Criminal Sanction'
The Wall Street Journal 2004 May 9

HSL324
Harris G.
U.S. Rules Morning-After Pill Can't Be Sold Over the Counter
The New York Times 2004 May 7

HSL325
Willman D.
Panel Wants Top Health Officials Off Drug Payrolls
The Los Angeles Times 2004 May 7

HSL326
Weiss R.
NIH Panel Backs Tighter Limits on Outside Income
The Washington Post 2004 May 7

HSL489
Cancer drug monopoly: SC issues notice
TOI Mumbai 2004 May 7

HSL481
Rabin R.
'We've been bamboozled' about cholesterol risks
Newsday.com 2004 May 6

HSL482
Vedantam S.
Drugmakers Prefer Silence On Test Data
The Washington Post 2004 May 6

HSL479
Bowe C.
Anti-depressant hearings set for this month
Financial Times 2004 May 5

HSL480
Double Dipping at NIH July 5, 2004
The Washington Post 2004 May 5

HSL2400
Helft PR, Ratain MJ, Epstein RA, Siegler M.
Inside information: Financial conflicts of interest for research subjects in early phase clinical trials.
J Natl Cancer Inst 2004 May 5; 96:(9):656-61
http://jncicancerspectrum.oxfordjournals.org/cgi/content/full/jnci;96/9/656

HSL323
Goozner M.
Disputing how drug costs are computed: The $800 Million Pill: The Truth Behind the Cost of New Drugs
Philadelphia Inquirer 2004 May 2

HSL127
Mayor S.
Cardiovascular disease threatens developing countries.
BMJ 2004 May 1; 328:(7447):1032
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036

HSL128
Mayor S.
Squeezing academic research into a commercial straitjacket.
BMJ 2004 May 1; 328:(7447):1036
http://www.bmj.com/content/328/7447/1036.1

HSL134
Burton B.
Drug industry to fight New Zealand's move to ban direct to consumer advertising.
BMJ 2004 May 1; 328:(7447):1036
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036-d

HSL322
Bibel B.
Best Consumer Health Books 2003
Library Journal 2004 May 1

HSL1157
Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May; 79:(5):432-7
http://www.academicmedicine.org/cgi/content/full/79/5/432

HSL1169
Sorensen TD, Song J, Westberg SM.
The limitation of good intentions: prescribing medications for the uninsured.
J Health Care Poor Underserved 2004 May; 15:(2):152-60

HSL1781
Brieger WR, Osamor PE, Salami KK, Oladepo O, Otusanya SA.
Interactions between patent medicine vendors and customers in urban and rural Nigeria.
Health Policy Plan 2004 May; 19:(3):177-82
http://heapol.oxfordjournals.org/cgi/reprint/19/3/177

HSL3588
Sterckx S.
Patents and access to drugs in developing countries: an ethical analysis.
Developing World Bioeth 2004 May; 4:(1):58-75
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15086374&query_hl=2&itool=pubmed_docsum

HSL7324
De las Cuevas C, Sanz E.
Do therapeutic indications of antidepressants change from one year to another?
Pharmacoepidemiol Drug Saf 2004 May; 13:(5):309-14
http://www3.interscience.wiley.com/cgi-bin/abstract/105556973/ABSTRACT?CRETRY=1&SRETRY=0

HSL9687
Divac N, Jasovic M, Djukic L, Vujnovic M, Babic D, Bajcetic M, Samardzic R.
Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia.
Pharmacoepidemiol Drug Saf 2004 May; 13:(5):315-22
http://www3.interscience.wiley.com/cgi-bin/abstract/107633037/ABSTRACT

HSL9691
Ho MR, Baker JE, Miller AL.
Simvastatin-induced rhabdomyolysis.
Am J Emerg Med 2004 May; 22:(3):234-5
http://linkinghub.elsevier.com/retrieve/pii/S0735675704000592

HSL9693
Rapaport MJ.
Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated.
Dermatol Surg 2004 May; 30:(5):761-3
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4725.2004.30213.x

HSL9723
Raymond EG, Spruyt A, Bley K, Colm J, Gross S, Robbins LA.
The North Carolina DIAL EC project: increasing access to emergency contraceptive pills by telephone.
Contraception 2004 May; 69:(5):367-72
http://linkinghub.elsevier.com/retrieve/pii/S0010782404000502

HSL9847
FDA Reanalyzes Data as Controversy Continues Over Antidepressant Use by Children and Adolescents
Psychiatr Serv 2004 May; 55:(5):598-599
http://www.psychservices.psychiatryonline.org/cgi/content/full/55/5/598

HSL20374
Pitts P
FDA decision making
Health Affairs 2004 May; 23:(3):287
http://content.healthaffairs.org/content/23/3/287.1.full

HSL321
Web Sparks Debate Over Drug Ads in Europe
iHealthBeat 2004 Apr 30

HSL5475
Mansfield PR.
Clarification and Update for AdWatch on Nexium dialogue
BMJ 2004 Apr 30; 328:
http://bmj.bmjjournals.com/cgi/eletters/328/7447/1035-a

HSL320
Kaplan J.
GOP gives green light to trade deal: Speaker Hastert has been sitting on bill for months
The Hill 2004 Apr 28

HSL319
Tierney P.
Novartis Offers Money Back on Blood Pressure Drugs
Reuters 2004 Apr 27

HSL316
Hannan E, Dunn A.
Unease over effects of medication
The Age 2004 Apr 26

HSL145
Charatan F.
Drug company raises US price of AIDS drug five-fold.
BMJ 2004 Apr 24; 328:(7446):974
http://bmj.bmjjournals.com/cgi/content/full/328/7446/974-a

HSL147
Tanne JH.
US consumer group names 'dirty dozen' dietary supplements
BMJ 2004 Apr 24; 328:(7446):975
http://bmj.bmjjournals.com/cgi/content/full/328/7446/975-c

HSL149
Lenzer J.
New Cochrane policy tightens limits on industry funding.
BMJ 2004 Apr 24; 328:(7446):976
http://bmj.bmjjournals.com/cgi/content/full/328/7446/976-a

HSL1420
Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
Lancet 2004 Apr 24; 363:(9418):1341-5
http://linkinghub.elsevier.com/retrieve/pii/S0140673604160431

HSL310
Depressing News on Depression
The New York Times 2004 Apr 23

HSL311
Dahir M.
Allow imported HIV/AIDS drugs: Abbott Labs' decision to raise by 500 percent the price of the AIDS drug Norvir underscores why the U.S. government must allow cheaper drugs to be imported into this country.
The Washington Blade 2004 Apr 23

HSL312
Laurance J.
Pharmaceutical companies accused of manipulating drug trials for profit
Independent.co.uk 2004 Apr 23

HSL313
Laurance J.
The link between industry, authors and their results
Independent.co.uk 2004 Apr 23

HSL314
Laurance J.
Firms become more aggressive as productivity crisis takes its toll
Independent.co.uk 2004 Apr 23

HSL315
Vedantam S.
Antidepressants Called Unsafe For Children: 4 Medications Singled Out In Analysis of Many Studies
Washington Post 2004 Apr 23

HSL309
Norman J.
Drug firm lobbyists intruded, Grassley says: 'Industry plants' attended several town meetings on a Medicare law in Iowa last week, the senator says.
Register Washington Bureau 2004 Apr 22

HSL307
Ferrie J.
When Good Drugs Go Bad: Adverse pharmaceutical reactions are a major killer, and a B.C. group is fighting to reduce the risk
The Tyee 2004 Apr 21

HSL308
Stewart H.
Aventis goes to court to block Sanofi
The Guardian 2004 Apr 21

HSL305
Study: Doctors Often Pick Costlier Drugs
The Associated Press 2004 Apr 20

HSL306
Younge G.
Gifts used to lure Aids business
The Guardian 2004 Apr 20

HSL9724
Wilson JF.
Cheaper drugs in foreign markets increase the focus on domestic drug prices.
Ann Intern Med 2004 Apr 20; 140:(8):677-80
http://www.annals.org/cgi/reprint/140/8/677.pdf

HSL143
Hutchinson MS.
Pharmaceutical companies and medical students: a student's view.
Med J Aust 2004 Apr 19; 180:(8):414
http://www.mja.com.au/public/issues/180_08_190404/hut10183_fm.html

HSL151
Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.
The ethics of pharmaceutical industry relationships with medical students.
Med J Aust 2004 Apr 19; 180:(8):411-4
http://www.mja.com.au/public/issues/180_08_190404/rog10715_fm.html

HSL340
Neergaard L
Maker to pull antidepressant off market
The Associated Press 2004 Apr 19

HSL1782
Breen KJ.
The medical profession and the pharmaceutical industry: when will we open our eyes?
Med J Aust 2004 Apr 19; 180:(8):409-10
http://www.mja.com.au/public/issues/180_08_190404/bre10055_fm.html

HSL302
MacAfee M.
Health Canada to get clearer picture of prescription drug sales, usage
Canadian Press 2004 Apr 18

Page 114 of 144 pages ‹ First  < 112 113 114 115 116 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909